Edition:
United States

Vital Therapies Inc (VTL.OQ)

VTL.OQ on NASDAQ Stock Exchange Global Select Market

4.95USD
20 Feb 2018
Change (% chg)

$-0.08 (-1.49%)
Prev Close
$5.03
Open
$5.00
Day's High
$5.10
Day's Low
$4.85
Volume
20,897
Avg. Vol
36,012
52-wk High
$6.65
52-wk Low
$2.25

Chart for

About

Vital Therapies, Inc. is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its product candidate, the ELAD System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's liver to regenerate to a healthy... (more)

Overall

Beta: 4.79
Market Cap(Mil.): $212.09
Shares Outstanding(Mil.): 42.21
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 180.40 17.28
EPS (TTM): -- -- --
ROI: -- -0.52 35.61
ROE: -- -3.30 17.17

BRIEF-Vital Therapies Appoints Russell J. Cox As Chief Executive Officer And Board Member

* VITAL THERAPIES APPOINTS RUSSELL J. COX AS CHIEF EXECUTIVE OFFICER AND BOARD MEMBER EFFECTIVE JANUARY 3, 2018

Dec 04 2017

BRIEF-Vital Therapies reports Q3 loss per share $0.30

* Vital therapies announces third quarter 2017 financial results

Oct 25 2017

Earnings vs. Estimates